Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer.

After adjusting for this, the chemotherapy regimen has an additional marginal significance ( P =0.02), with patients receiving anthracycline-based chemotherapy more likely to achieve a pCR than those receiving other regimens ( Table 2 ).

also in 5,069 other papers